# Balkanpharma Dupnitsa AD – FDA Inspection, Aug 28, 2015

Source: https://www.keypedia.com/records/fda_inspections/balkanpharma-dupnitsa-ad/2c31f66a-4897-40e5-8cf0-474da9609e3f
Source feed: FDA_Inspections

> FDA inspection 945384 of Balkanpharma Dupnitsa AD, August 28, 2015. Classification: No Action Indicated (NAI). 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 945384
- Company Name: Balkanpharma Dupnitsa AD
- Inspection Date: 2015-08-28
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1222624 - 2023-09-29](https://www.keypedia.com/records/fda_inspections/balkanpharma-dupnitsa-ad/0617b475-59cf-4eb8-b3df-7c4fba341ed6)
- FDA Inspection 1140148 - 2019-03-01
- FDA Inspection 1057710 - 2018-06-08
- FDA Inspection 1012588 - 2017-04-07

Company: https://www.keypedia.com/companies/balkanpharma-dupnitsa-ad/5cc89838-f87e-4692-a4a2-87d30a2b557b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
